Clinical trial
Research Study for Major Depressive Disorder: Investigation of Glutamate…
NCT00419003 · Baylor College of Medicine, Other · Completed
Key facts
| NCT number | NCT00419003 |
|---|---|
| Title | Research Study for Major Depressive Disorder: Investigation of Glutamate Medications |
| Official title | Continuation Riluzole in the Prevention of Relapse Following Ketamine in Major Depression |
| Lead sponsor | Baylor College of Medicine, Other |
| Collaborators | National Alliance for Research on Schizophrenia and Depression National Center for Research Resources (NCRR) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Major Depression |
| Intervention type | Drug |
| Interventions | Lamotrigine, Ketamine, Riluzole |
| Enrollment | 26 |
| Start date | Dec 1, 2006 |
| Primary completion | Jul 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Jan 5, 2007 |
| Last update posted | Jul 31, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: